Navigation Links
Opiates Better Than Sedatives For Treating Newborns In Withdrawal

For years, sedatives have been the gold standard for treating newborns suffering from opiate withdrawal. However, new research suggests that opiates themselves are superior to sedatives for treating infants born to women who used heroin or methadone while pregnant.

Opiates appear to better "ameliorate the withdrawal, facilitate feeding and potentially reduce the likelihood of seizures," according to two new systematic reviews done by David Osborn, a neonatologist at the Royal Prince Alfred Hospital in Sydney, Australia, and colleagues.

The researchers also found that infants treated with opiates regained birth weight more quickly than those who only received supportive care.

According to their analysis, the use of opiates instead of sedatives or supportive care alone shortens the duration of supportive care by an average of four days. When compared to diazepam (Valium), opiates reduce the incidence of treatment failure.

However, infants treated with opiates had longer hospital stays than those treated with phenobarbitone, the sedative most often used in these cases. When sedatives only were compared, phenobarbitone was more likely than diazepam to reduce treatment failure.

The reviews appear in the July issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

The reviews included 13 studies with a total of 890 infants of mothers who had used opiates with or without other drugs (including antidepressants, sleep aids and marijuana) during pregnancy. Researchers say two of the studies may have included identical patients.

Newborns suffering from neonatal abstinence syndrome (NAS) exhibit seizures, poor feeding, diarrhea and vomiting that lead to excessive weight loss and dehydr
'"/>

Source:Center for the Advancement of Health


Page: 1 2

Related biology news :

1. Institute for Systems Biology Symposium Addresses Need for Better Computational Tools
2. Protein Discovery Could Unlock The Secret To Better TB Treatment
3. Computational Tool Predicts How Drugs Work In Cells, Advancing Efforts To Design Better Medicines
4. Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy
5. Better beetle sought for salt cedar control
6. Better sludge through metagenomics
7. Better assessment of transfusions could save blood
8. Better health twice as likely for nonsmokers who live and work with smoking restrictions
9. Potential Drug Target For Treating Cocaine Abuse Found
10. NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma
11. Treating populations infected with HIV and latent TB could speed the emergence of drug-resistant TB

Post Your Comments:
(Date:11/24/2009)...et science is opening new doors to understanding h...the hearing of a marine mammal or if they hear it...ed X-ray scanners that NASA uses to detect flaws i...is now allowing scientists to peek inside the gian...d three-dimensional replicas of a whale,s hearing ...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wi...a report revealing that the last remaining populat...cantly due to the rising tide of poaching and habi... help inform Russian officials of what needs to be...d,s biggest cat. , The report was r...
(Date:11/23/2009)...INNATINew research presents strong evidence that t...both outdoor traffic-related pollution and indoor ...n one or the other exposure alone. , Environme...nati (UC) College of Medicine have shown that chil...d particles and indoor endotoxin during early life...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Predictors of disease behavior change in Crohn 26 23146 3Bs disease 54046 1Estrogen dependent switch tempers killing activity of immune cells 9527 1Estrogen dependent switch tempers killing activity of immune cells 9527 2STAT3 gene regulates cancer stem cells in brain cancer 9525 1STAT3 gene regulates cancer stem cells in brain cancer 9525 2
...terdam, 2 December 2008 - Elsevier is delighted to...e the official publisher of the quarterly peer-rev... ( www.elsevier.com/locate/esd ) on behalf of the ...nable development involves meeting present human n...ons. Energy is central to providing many of these ...
... Arctic is undergoing rapid transformation due to ...s ERS and Envisat satellites have been providing s... These long term data sets in combination with ESA... newly adopted European Commission policy called ,...policy highlights new opportunities in the region ...
...PEL HILL How marine animals find their way back t...ross thousands of miles of open ocean has mystifie...iologists at the University of North Carolina at C... the secret. , At the beginning of their lives, s...of their home area and "imprint" on it, according ...
Other Biology News:New publishing partnership for Energy for Sustainable Development 2ESA satellites focusing on the Arctic 2No place like home: New theory for how salmon, sea turtles find their birthplace 2No place like home: New theory for how salmon, sea turtles find their birthplace 3
(Date:11/24/2009)...24/PRNewswire-FirstCall/--Sigma-AldrichCorporation...renceonTuesday,December1stat1:45PMGMTinLondon,7:45...adcastovertheInternetavailableat http://inve s ...ebcast"icontoaccessthisfile. ,, AboutSigma-Al...echnologycompany.Itschemicalandbiochemicalproducts...
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Na...elopingandcommercializingnovelpainmanagementtherap...hiefExecutiveOfficer,isscheduledtopresentatthe21st...ember1-2,2009atTheNewYorkPalaceHotelinNewYork,NewY...ncialOfficer,willbeavailabletorespondtoquestionsdu...
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,...nomicHealth,sExecutiveChairman,willpresentatthe21s...tyonTuesday,December1,2009at10:00a.m.ET. ,, Toa...sentation,visittheInvestorRelationssectionofGenomi...om .Pleaseconnecttothewebsiteatleast15minutesprior...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...h,announced that Sustenex(TM), its all-natural dai...e. Each Sustenex(TM) capsule contains at least 2,b...rietary, patented strain,of Bacillus coagulans des.... Sustenex(TM) with GanedenBC30 Probiotic is desig...elivering ten times more probiotic cells,than most...
...egic and operational leadership to support expans... opportunities, COLUMBIA, Md., A...ent of Brad L. Stewart as President of the Company...elops and manufactures research and in,vitro diagn... assay,cell-mediated immunity (CMI)., (Photo: ht...
...e,Chairman and CEO, Egenix, Inc., announced the ap...e company,s scientific advisory board. Dr.,Petryla...Columbia,University Medical Center where he is Dir...l Oncology. He is the co-author of numerous peer r... in the treatment of cancers of,prostate, kidney, ...
Other Biology Technology:Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 2Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 3Cylex Announces Brad L. Stewart as President of the Company 2
Toxoplasma IgG ELISA Kit, Single from Bio-Quant Inc.
Agarose, low melting/gelling temperature high MW separation (> 1000 bp) from GE Healthcare, formerly Amersham Biosciences
Rubella IgM ELISA Kit, Single from Bio-Quant Inc.
Chlamydia pneumonia IgA ELISA Kit, Single from Bio-Quant Inc.
Biology Products: